201 related articles for article (PubMed ID: 25226451)
1. Activation of a novel c-Myc-miR27-prohibitin 1 circuitry in cholestatic liver injury inhibits glutathione synthesis in mice.
Yang H; Li TW; Zhou Y; Peng H; Liu T; Zandi E; Martínez-Chantar ML; Mato JM; Lu SC
Antioxid Redox Signal; 2015 Jan; 22(3):259-74. PubMed ID: 25226451
[TBL] [Abstract][Full Text] [Related]
2. Induction of avian musculoaponeurotic fibrosarcoma proteins by toxic bile acid inhibits expression of glutathione synthetic enzymes and contributes to cholestatic liver injury in mice.
Yang H; Ko K; Xia M; Li TW; Oh P; Li J; Lu SC
Hepatology; 2010 Apr; 51(4):1291-301. PubMed ID: 20146260
[TBL] [Abstract][Full Text] [Related]
3. Anti-Inflammatory Effects of Vardenafil Against Cholestatic Liver Damage in Mice: a Mechanistic Study.
El-Agamy DS; Almaramhy HH; Ahmed N; Bojan B; Alrohily WD; Elkablawy MA
Cell Physiol Biochem; 2018; 47(2):523-534. PubMed ID: 29794447
[TBL] [Abstract][Full Text] [Related]
4. Molecular mechanisms of lipopolysaccharide-mediated inhibition of glutathione synthesis in mice.
Tomasi ML; Ryoo M; Yang H; Iglesias Ara A; Ko KS; Lu SC
Free Radic Biol Med; 2014 Mar; 68():148-58. PubMed ID: 24296246
[TBL] [Abstract][Full Text] [Related]
5. Mechanism and significance of changes in glutamate-cysteine ligase expression during hepatic fibrogenesis.
Ramani K; Tomasi ML; Yang H; Ko K; Lu SC
J Biol Chem; 2012 Oct; 287(43):36341-55. PubMed ID: 22942279
[TBL] [Abstract][Full Text] [Related]
6. Activation of nuclear factor (erythroid-2 like) factor 2 by toxic bile acids provokes adaptive defense responses to enhance cell survival at the emergence of oxidative stress.
Tan KP; Yang M; Ito S
Mol Pharmacol; 2007 Nov; 72(5):1380-90. PubMed ID: 17724089
[TBL] [Abstract][Full Text] [Related]
7. Tumour necrosis factor alpha induces co-ordinated activation of rat GSH synthetic enzymes via nuclear factor kappaB and activator protein-1.
Yang H; Magilnick N; Ou X; Lu SC
Biochem J; 2005 Oct; 391(Pt 2):399-408. PubMed ID: 16011481
[TBL] [Abstract][Full Text] [Related]
8. Participation of nuclear factor (erythroid 2-related), factor 2 in ameliorating lithocholic acid-induced cholestatic liver injury in mice.
Tan KP; Wood GA; Yang M; Ito S
Br J Pharmacol; 2010 Nov; 161(5):1111-21. PubMed ID: 20977460
[TBL] [Abstract][Full Text] [Related]
9. Willow bark extract increases antioxidant enzymes and reduces oxidative stress through activation of Nrf2 in vascular endothelial cells and Caenorhabditis elegans.
Ishikado A; Sono Y; Matsumoto M; Robida-Stubbs S; Okuno A; Goto M; King GL; Keith Blackwell T; Makino T
Free Radic Biol Med; 2013 Dec; 65():1506-1515. PubMed ID: 23277146
[TBL] [Abstract][Full Text] [Related]
10. Prohibitin 1 suppresses liver cancer tumorigenesis in mice and human hepatocellular and cholangiocarcinoma cells.
Fan W; Yang H; Liu T; Wang J; Li TW; Mavila N; Tang Y; Yang J; Peng H; Tu J; Annamalai A; Noureddin M; Krishnan A; Gores GJ; Martínez-Chantar ML; Mato JM; Lu SC
Hepatology; 2017 Apr; 65(4):1249-1266. PubMed ID: 27981602
[TBL] [Abstract][Full Text] [Related]
11. Induction of lung glutathione and glutamylcysteine ligase by 1,4-phenylenebis(methylene)selenocyanate and its glutathione conjugate: role of nuclear factor-erythroid 2-related factor 2.
Emmert SW; El-Bayoumy K; Das A; Sun YW; Amin S; Desai D; Aliaga C; Richie JP
Free Radic Biol Med; 2012 May; 52(10):2064-71. PubMed ID: 22542796
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of MAFG Dysregulation in Cholestatic Liver Injury and Development of Liver Cancer.
Liu T; Yang H; Fan W; Tu J; Li TWH; Wang J; Shen H; Yang J; Xiong T; Steggerda J; Liu Z; Noureddin M; Maldonado SS; Annamalai A; Seki E; Mato JM; Lu SC
Gastroenterology; 2018 Aug; 155(2):557-571.e14. PubMed ID: 29733835
[TBL] [Abstract][Full Text] [Related]
13. Quercetin attenuates toosendanin-induced hepatotoxicity through inducing the Nrf2/GCL/GSH antioxidant signaling pathway.
Jin Y; Huang ZL; Li L; Yang Y; Wang CH; Wang ZT; Ji LL
Acta Pharmacol Sin; 2019 Jan; 40(1):75-85. PubMed ID: 29921882
[TBL] [Abstract][Full Text] [Related]
14. Decline in transcriptional activity of Nrf2 causes age-related loss of glutathione synthesis, which is reversible with lipoic acid.
Suh JH; Shenvi SV; Dixon BM; Liu H; Jaiswal AK; Liu RM; Hagen TM
Proc Natl Acad Sci U S A; 2004 Mar; 101(10):3381-6. PubMed ID: 14985508
[TBL] [Abstract][Full Text] [Related]
15. Targeting of Gamma-Glutamyl-Cysteine Ligase by miR-433 Reduces Glutathione Biosynthesis and Promotes TGF-β-Dependent Fibrogenesis.
Espinosa-Diez C; Fierro-Fernández M; Sánchez-Gómez F; Rodríguez-Pascual F; Alique M; Ruiz-Ortega M; Beraza N; Martínez-Chantar ML; Fernández-Hernando C; Lamas S
Antioxid Redox Signal; 2015 Nov; 23(14):1092-105. PubMed ID: 25353619
[TBL] [Abstract][Full Text] [Related]
16. Dysregulation of glutathione synthesis during cholestasis in mice: molecular mechanisms and therapeutic implications.
Yang H; Ramani K; Xia M; Ko KS; Li TW; Oh P; Li J; Lu SC
Hepatology; 2009 Jun; 49(6):1982-91. PubMed ID: 19399914
[TBL] [Abstract][Full Text] [Related]
17. Competition of nuclear factor-erythroid 2 factors related transcription factor isoforms, Nrf1 and Nrf2, in antioxidant enzyme induction.
Chepelev NL; Zhang H; Liu H; McBride S; Seal AJ; Morgan TE; Finch CE; Willmore WG; Davies KJ; Forman HJ
Redox Biol; 2013; 1(1):183-9. PubMed ID: 24024152
[TBL] [Abstract][Full Text] [Related]
18. Deregulated methionine adenosyltransferase α1, c-Myc, and Maf proteins together promote cholangiocarcinoma growth in mice and humans(‡).
Yang H; Liu T; Wang J; Li TW; Fan W; Peng H; Krishnan A; Gores GJ; Mato JM; Lu SC
Hepatology; 2016 Aug; 64(2):439-55. PubMed ID: 26969892
[TBL] [Abstract][Full Text] [Related]
19. Insulin-like growth factor 1 specifically up-regulates expression of modifier subunit of glutamate-cysteine ligase and enhances glutathione synthesis in SH-SY5Y cells.
Takahashi S; Hisatsune A; Kurauchi Y; Seki T; Katsuki H
Eur J Pharmacol; 2016 Jan; 771():99-106. PubMed ID: 26687633
[TBL] [Abstract][Full Text] [Related]
20. Switch from Mnt-Max to Myc-Max induces p53 and cyclin D1 expression and apoptosis during cholestasis in mouse and human hepatocytes.
Yang H; Li TW; Ko KS; Xia M; Lu SC
Hepatology; 2009 Mar; 49(3):860-70. PubMed ID: 19086036
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
